Endometroid Adenocarcinoma: A Possibility after Hysterectomy

Nikhil Purandare, Gillian Ryan, Fathl Ramli, Kara Purcell, Andrew Curtain, Morgan McCourt
In: Journal of South Asian Federation of Obstetrics and Gynaecology · 2010 · vol. 2(3) , pp. 230–232 · doi:10.5005/jp-journals-10006-1108 · W2114099602
article OA: bronze CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-12 ⓘ

This case report describes a 57-year-old woman with a history of endometriosis who developed an endometrioid adenocarcinoma after hysterectomy and bilateral salpingo-oophorectomy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Malignant transformation is a rare sequelae of endometriosis. We report a case of Mrs. GR who was a 57-year-old, nulliparous woman. She presented with passing fecal matter vaginally and a left pelvic mass increasing in size and discomfort. She had a history of subtotal hysterectomy and bilateral salpingo-oophrectomy for endometriosis and was incidentally found to have a benign Sertoli-Leydig cell tumor in a single ovary. She subsequently had a CT scan confirming the presence of a mass greater than 9 cm in size. The biopsy suggested endometrioid adenocarcinoma. Our case shows possibility of malignant transformation of endometriosis after hysterectomy and bilateral salpingo-oophrectomy in a patient with a prior history of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (17)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK